You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sarilumab

Showing 1 - 25 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast, Metastatic, Triple Negative Trial in Gainesville, Jacksonville (Capecitabine, Sarilumab 150mg or 200 mg plus

Active, not recruiting
  • Breast
  • +4 more
  • Gainesville, Florida
  • +1 more
Feb 2, 2023

Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))

Not yet recruiting
  • Lung Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

An Observational Study on Sarilumab-exposed Pregnancies

Recruiting
  • Rheumatoid Arthritis -Exposure During Pregnancy
  • Sarilumab SAR153191 (REGN88)
  • New York, New York
  • +1 more
Jul 5, 2022

COVID Trial in United States (SARILUMAB)

Completed
Has Results
  • COVID
  • SARILUMAB
  • West Haven, Connecticut
  • +4 more
Sep 14, 2022

Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)

Not yet recruiting
  • Melanoma
  • Unresectable Melanoma
  • Sarilumab
  • +2 more
  • Los Angeles, California
  • +3 more
Aug 4, 2022

Application of N-of-1 Rheumatoid Arthritis

Not yet recruiting
  • Arthritis, Rheumatoid
  • Boston, Massachusetts
    Tufts Medical Center
Aug 24, 2023

Sarcoidosis Trial in Palo Alto (Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1, Placebos)

Active, not recruiting
  • Sarcoidosis
  • Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1
  • Placebos
  • Palo Alto, California
    Stanford University
Jan 12, 2022

Interleukin 6 Receptor Antagonists in Corona Virus Disease 19

Recruiting
  • Corona Virus Infection
  • ELISA
  • Assiut, Egypt
    AssiutU
Feb 2, 2023

Morphea, Plaque Form Trial in Boston (Sarilumab)

Withdrawn
  • Morphea, Plaque Form
  • Sarilumab
  • Boston, Massachusetts
    CURTIS (Massachusetts General Hospital)
Aug 31, 2021

COVID19 Trial in Milano (Sarilumab Prefilled Syringe)

Recruiting
  • COVID19
  • Sarilumab Prefilled Syringe
  • Milano, MI, Italy
    Divisione Clinicizzata di Malattie Infettive, ASST FBF-Sacco
Jul 19, 2021

Juvenile Idiopathic Arthritis Trial in Worldwide (Sarilumab SAR153191 (REGN88))

Recruiting
  • Juvenile Idiopathic Arthritis
  • Sarilumab SAR153191 (REGN88)
  • Tucumán, Argentina
  • +29 more
Jan 9, 2023

SARS-CoV 2, SARS Trial in Córdoba (Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA], Sarilumab 400 MG/2.28 ML

Completed
  • SARS-CoV 2
  • SARS
  • Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]
  • +2 more
  • Córdoba, Spain
    Hospital Universitario Reina Sofía
Jul 6, 2021

Inpatient COVID-19 Treatments

Active, not recruiting
  • COVID-19
  • Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)
  • New York, New York
    Aetion, Inc.
Jan 12, 2023

Skin Inflammation, Allergic Contact Dermatitis Trial in Worcester (drug, other, device)

Recruiting
  • Skin Inflammation
  • Allergic Contact Dermatitis
  • Squaric Acid Dibutyl Ester
  • +12 more
  • Worcester, Massachusetts
    University of Massachusetts Chan Medical School
Sep 6, 2022

Arthritis, Rheumatoid, Interaction Trial in Esbjerg, Odense, Sønderborg (Tocilizumab, Sarilumab)

Terminated
  • Arthritis, Rheumatoid
  • Interaction
  • Esbjerg, Region Of Southern Denmark, Denmark
  • +2 more
Jan 20, 2023

Juvenile Idiopathic Arthritis Trial in Worldwide (Sarilumab)

Active, not recruiting
  • Juvenile Idiopathic Arthritis
  • Sarilumab
  • Los Angeles, California
  • +34 more
May 10, 2022

Rheumatoid Arthritis Trial (TNFi, Anti-IL6, JAKi)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Mar 22, 2022

Giant Cell Arteritis Trial in Worldwide (Sarilumab SAR153191, Sarilumab matching , Prednisone)

Terminated
Has Results
  • Giant Cell Arteritis
  • Sarilumab SAR153191
  • +3 more
  • Boca Raton, Florida
  • +60 more
Mar 15, 2022

Covid-19 Trial in Madrid (Sarilumab, Standar of care)

Completed
  • Covid-19
  • Sarilumab
  • Standar of care
  • Madrid, Spain
    Hospital Universitario de la Princesa
Feb 10, 2021

Corona Virus Infection Trial in Worldwide (Sarilumab SAR153191, Placebo)

Completed
Has Results
  • Corona Virus Infection
  • Sarilumab SAR153191
  • Placebo
  • Caba, Argentina
  • +46 more
Mar 15, 2022

COVID-19 Drug Treatment Trial in Pamplona, Madrid (Sarilumab)

Unknown status
  • COVID-19 Drug Treatment
  • Sarilumab
  • Pamplona, Navarra, Spain
  • +1 more
Dec 14, 2020

Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)

Recruiting
  • Rheumatoid Arthritis
  • Omaha, Nebraska
    University of Nebraska Medical Center
Oct 28, 2021

Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Adalimumab, Placebo (for sarilumab))

Completed
Has Results
  • Rheumatoid Arthritis
  • Sarilumab
  • +3 more
  • Covina, California
  • +85 more
Mar 15, 2022

Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))

Not yet recruiting
  • Rheumatoid Arthritis
  • Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
  • (no location specified)
Nov 12, 2021

Rheumatoid Arthritis Trial in Aventura (Sarilumab)

Unknown status
  • Rheumatoid Arthritis
  • Sarilumab
  • Aventura, Florida
    AARDS Research, Inc
Aug 10, 2020